A U.S. Food and Drug Administration (FDA) expert panel will weigh authorization of Pfizer’s COVID-19 vaccine for children aged five to 11 on Tuesday as it prepares to vote on a recommendation. If the Centers for Disease Control and Prevention (CDC) ultimately endorses the shot, the vaccines could start being administered as soon as next week.
CDC
U.S. FDA panel weighs authorization of Pfizer’s COVID-19 vaccine for kids
More Videos
-
Health Matters: RFK’s advisory panel recommends restrictions on MMRV vaccines
-
Former CDC director Monarez says she was fired for refusing RFK Jr.’s demands
-
‘Lies!’: RFK. Jr. clashes with senators on vaccines, CDC chaos in tense hearing
-
CDC names Jim O’Neill interim director replacing Susan Monarez after controversial dismissal
-
Health Matters: Jim O’Neill to serve as acting CDC director as leadership turmoil leaves agency reeling
-
Trump administration faces fallout over CDC and Federal Reserve firing attempts
You are viewing an Accelerated Mobile Webpage.
View Original Article